OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 17, 2017
Caladrius is selling the remaining percentage of the subsidiary in order to focus on cell therapy development.
March 02, 2017
A robust quality agreement and good communication scheme can help avoid and alleviate regulatory concerns.
Moving global manufacturing operations may be more complicated than it appears.
Pharmaceutical Technology asked Siegfried Schmitt, principal consultant at PAREXEL, about the importance of quality agreements in the sponsor/contractor relationship.
March 01, 2017
The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.
February 23, 2017
The industry is becoming more consolidated, but there needs to be some strategy behind the mergers and acquisitions.
February 17, 2017
SGS expands its elemental impurity testing services at its laboratory in Villeneuve-la-Garenne, France.
February 14, 2017
Quotient Clinical’s addition of CDMO QS Pharma increases the company’s footprint in the US an adds high potency molecule capability.
February 02, 2017
The outlook for the CMO and CDMO industry may be affected by ever-changing politics.